Updates are available Correction dated 2023-06-29
Click to view Correction: https://doi.org/10.1007/s00259-023-06304-2
-
Authors
Gear, Jonathan http://orcid.org/0000-0002-4292-6149
Stokke, Caroline
Terwinghe, Christelle
Gnesin, Silvano
Sandström, Mattias
Tran-Gia, Johannes
Cremonesi, Marta
Cicone, Francesco
Verburg, Fredrik
Hustinx, Roland
Giovanella, Luca
Herrmann, Ken
Gabiña, Pablo Minguez
-
Funding
Funding for this research was provided by:
NIHR Biomedical Research Centre at The Royal Marsden and the ICR
- License Information
-
More Information
Article History
Received: 11 February 2023
Accepted: 4 April 2023
First Online: 22 April 2023
Change Date: 29 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-023-06304-2
Declarations
:
: This manuscript does not contain proprietary research involving either humans or animals.
: This manuscript does not contain proprietary human data; accordingly an informed consent is not applicable.
: This guide summarises the views of the co-authoring EANM Committee members. It reflects recommendations for which the EANM cannot be held responsible. The recommendations should be taken into the context of good practise of nuclear medicine and do not substitute for national and international legal or regulatory provisions.
: KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, all outside the submitted work. LG reports personal fees from Roche Diagnostics and SNIBE for advisory board participation, and research support from Roche Diagnostics., all outside the submitted work.
